Inhibrx Biosciences Inc (INBX)
R&D Expense Growth
-3.19%
Quarterly · Period ending:
INBX R&D Expense Growth
Latest reported-3.19%period ending
Latest reported-3.19%period ending
INBX Quarterly R&D Growth (QoQ) (0.00% → -3.19%)
Latest values, visible window
High-resolution chart · PNG
INBX r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -3.192% | |
| -2.6115% | |
| -11.1652% | |
| 28.1493% | |
| -39.6182% | |
| 10.5194% | |
| -12.7272% | |
| -43.4691% | |
| 6.348% | |
| -22.2926% | |
| 115.0432% | |
| 12.3819% | |
| -8.8428% | |
| 21.996% | |
| 22.1264% | |
| -16.6254% | |
| 20.1285% | |
| 33.7362% | |
| 0.7033% | |
| 3.2566% | |
| 8.9062% | |
| -6.9617% | |
| -10.9341% | |
| 4.5483% | |
| 11.5068% | |
| 38.5329% | |
| -3.9265% | |
| 5.0189% | |
| 14.1491% | |
| 127.8846% | |
| 0% | |
| -21.1893% | |
| 47.8804% | |
| 0% |